Latest
Hot
Unlock Pro Investors’ Money-Making Secrets
Join Futubull Community! Now Connect Directly with Top Investors & Public Company Executives
方達控股IPO，能否複製複製藥明康得神話？
方達控股自5月17日起招股，集資額為1.6061億美元，於5月30日登陸港交所。
方達控股是繼藥明生物後又一備受關注的CRO（合同研究機構）公司。有高瓴資本、景林資產等均有參與認購，泰格醫藥持有方達醫藥51.45%的股權。你認為方達控股上市後表現將會如何？
方達控股自5月17日起招股，集資額為1.6061億美元，於5月30日登陸港交所。
方達控股是繼藥明生物後又一備受關注的CRO（合同研究機構）公司。有高瓴資本、景林資產等均有參與認購，泰格醫藥持有方達醫藥51.45%的股權。你認為方達控股上市後表現將會如何？
方達控股是繼藥明生物後又一備受關注的CRO（合同研究機構）公司。有高瓴資本、景林資產等均有參與認購，泰格醫藥持有方達醫藥51.45%的股權。你認為方達控股上市後表現將會如何？
Views
15K
Posts
10
Follow
Join topic
Similar Topics
More
- 2026 IPO bonanza! Over 90% of new stocks rose on their debut!59.5M Views · 16K Posts
- Xuanzhu Biotech opened more than 150% higher on its first day. Would you still consider investing?1.1M Views · 333 Posts
- Is the Gray Market Surge Just the Beginning? GenFleet Therapeutics Soars Over 140% on Debut!1.3M Views · 510 Posts
- Zijin Mining and XPL Soar on Debut! Is It Too Late to Buy In?9.3M Views · 1417 Posts
- Dahon Tech's stock opened 36% higher on its first day. Should we take profits or double down?1.3M Views · 199 Posts